Prof. Dr. Jian-Jun Li is a renowned cardiologist at Fu Wai Hospital, Chinese Academy of Medical Science, Beijing. He holds an MD from Wuhan University, a PhD from Kyushu University, Japan, and completed post-doctoral training in the USA. As Professor and Consultant at the Cardiometabolic Center, his research focuses on dyslipidemia, inflammation, atherosclerosis, and interventional cardiology. He serves as Vice President of the Chinese Molecular College of Cardiology and is a national expert in cardiovascular disease prevention. Prof. Li has received multiple prestigious science awards, recognizing his significant contributions to cardiovascular medicine and public health in China.

AUTHOR PROFILE

Scopus Profile

👨‍🎓 EARLY ACADEMIC PURSUITS:

Prof. Dr. Jian-Jun Li began his academic journey in medicine at Wuhan University, China, where he pursued his MD from 1978 to 1986. With a strong foundation in clinical and theoretical medical sciences, he furthered his education with a PhD from Kyushu University, Japan (1991–1995)—a prestigious institution known for its cutting-edge biomedical research. He then expanded his international experience through a Post-doctoral Fellowship at the University of Louisville, USA (1995–1997), where he explored advanced cardiovascular research.

👨‍⚕️ PROFESSIONAL ENDEAVORS:

Currently, Prof. Dr. Jian-Jun Li serves as a Professor and Consultant at the Cardiometabolic Center, Fu Wai Hospital, affiliated with the Chinese Academy of Medical Science and Peking Union Medical College, Beijing. This esteemed role places him at the heart of China’s most influential medical and research institution for cardiovascular health.

In addition to his primary role:

•  He is the Vice President of the Chinese Molecular College of Cardiology.

•  He is a Member of the National Expert Committee on Prevention and Control of Cardiovascular Disease.

•  He is an Expert Member of the Chinese Doctor Union.

🧪 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOLOGY:

Prof. Dr. Jian-Jun Li’s research work is both broad and impactful, focusing on some of the most critical issues in modern cardiology:

• Dyslipidemia – studying abnormal lipid levels and their role in cardiovascular disease.

• Inflammation and Atherosclerosis – understanding how chronic inflammation contributes to plaque buildup in arteries.

• Interventional Cardiology – innovating and improving minimally invasive procedures to treat cardiovascular conditions.

His work bridges the gap between molecular cardiology and clinical applications, aiming for preventive and therapeutic breakthroughs in cardiovascular health.

🏆 IMPACT AND INFLUENCE:

Prof. Li’s contributions have been nationally and internationally acknowledged:

• Secondary Awards of National Science and Technology in Advance (2002)

• Hubei Province Awards of Chinese Science and Technology in Advance for five consecutive years: 1999–2003

These awards reflect the consistency, excellence, and innovation in his work, particularly in translational medicine and cardiovascular disease control.

📚 ACADEMIC CITES AND COLLABORATIONS:

Prof. Li has been widely cited in national and international scientific publications. His peer-reviewed research articles in leading cardiology and internal medicine journals have significantly influenced clinical practices in China and abroad. His collaborations with researchers in Japan, the USA, and Europe have expanded the global reach of Chinese cardiovascular research.

🧬 LEGACY AND FUTURE CONTRIBUTIONS:

As a visionary academic and physician, Prof. Li’s legacy is cemented in:

•  Mentoring the next generation of cardiologists and researchers in China.

•  Shaping policy frameworks for cardiovascular disease prevention nationwide.

•  Advancing personalized medicine approaches in dyslipidemia and atherosclerosis.

•  Promoting international cooperation in cardiovascular research.

His future contributions are likely to continue influencing both clinical and molecular cardiology, especially in integrative therapeutic techniques and public health strategies.